Targeting Metabolism as a Therapeutic Approach for High-Risk MYCN-Driven Neuroblastoma |
University of Pennsylvania / Nicole Anderson, PhD |
Young Investigator Grants |
2016 |
Pennsylvania |
Exploring a novel immunotherapy: cooperation of endogenous CD8+ t-cells and exogenous, allogeneic CD4+ t-cells.
|
The Johns Hopkins University School of Medicine / Heather Symons |
Young Investigator Grants |
2009 |
Maryland |
Development of Targeted Therapies in High Risk Childhood Acute Lymphoblastic Leukemia |
Children’s Hospital of Philadelphia / Sarah Tasian |
Young Investigator Grants |
2012 |
Pennsylvania |
Cooperating Signaling Networks Regulate Cell Survival of Pediatric Ph-like ALL |
University of Pennsylvania / Christian Hurtz, PhD |
Young Investigator Grants |
2018 |
Pennsylvania |
Mechanisms of CNOT3 Tumor Suppression in T-ALL and Identification of New Drugs That Specifically Kill CNOT3-Deficient T-ALL Cells |
Dana-Farber Cancer Institute / Zhaodong Li, PhD |
Young Investigator Grants |
2014 |
Massachusetts |
The Regulation of Hematopoietic Stem Cell Function by Granulocyte-Colony Stimulating Factor |
Washington University / Laura Schuettpelz, MD, PhD |
Young Investigator Grants |
2013 |
Missouri |
Preclinical Efficacy of Daratumumab in T Cell Acute Lymphoblastic Leukemia |
New York University School of Medicine / Karen Bride, MD/PhD |
Young Investigator Grants |
2017 |
New York |
CDK8 as a New Therapeutic Target in Alveolar Rhabdomyosarcoma |
Dana-Farber Cancer Institute / Susu Zhang, PhD |
Young Investigator Grants |
2023 |
Massachusetts |
Engager T Cells: A Novel Immunotherapeutic for AML |
University of Michigan / Challice Bonifant, MD, PhD |
Young Investigator Grants |
2015 |
Michigan |
Development of An Innovative Treatment Strategy for Neuroblastoma and Other Pediatric Tumors: A Novel Phospholipid Ester Analogue and its Multifunctional Cancer-targeting Nanoconstruct |
University of Wisconsin - Madison / Mario Otto |
Young Investigator Grants |
2012 |
Wisconsin |